Global Partners

Horizontal Collaborations with Global Partners

Although Otsuka independently discovers new drugs, we also value working with our global partners in horizontal collaborations. We prefer partnerships of equals (horizontal collaborations) supported by candid and frequent discussions, whereas major pharmaceutical companies more commonly pursue corporate acquisitions and outright purchase of promising drug candidates (vertical approach.)

Medical contributions for over a decade on the co-development and co-marketing of antipsychotic drugs

Bristol-Myers Squibb Company (US)

Established: 1887
Bristol-Myers Squibb is a global biopharmaceutical company which brings together a foundation as a large pharmaceutical company with a tradition, and a position as a cutting-edge biotechnology company.

“Aligning around the patients.
There is no other job, in my mind,
that is more fulfilling.”

UCB S.A. (Belgium)

Established: 1928
UCB is a global biopharmaceutical company researching, developing, and marketing pharmaceuticals and biotech products mainly in the fields of the central nervous system, immune system, and inflammation.

“The central nervous system is a very difficult area. Lundbeck thinks with a long-term perspective and is not fixated on short-term goals.”

H. Lundbeck A/S (Denmark)

Established: 1915
Lundbeck is one of the world’s leading pharmaceutical companies specializing in central nervous system disorders. Its products encompass disorders such as depression and anxiety, schizophrenia, epilepsy, and Huntington’s, Alzheimer’s and Parkinson’s diseases.

Lists of Global Partners

Pharmaceutical Products

Central Nervous System

Bristol-Myers Squibb Company Bristol-Myers Squibb
Company (US)
Distribution and management of safety information of ABILIFY
ucb UCB S.A. (Belgium) Co-development and co-promotion of E Keppra in Japan

Exclusive rights for developing and marketing Neupro Patch jn Japan

Lundbeck H. Lundbeck A/S
(Denmark)
Co-development and co-promotion of Abilify Maintena

Co-development and co-commercialization of brexpiprazole

Oncology

aspen Aspen Pharmacare
Australia
Business related to Busulfex in Australia
GW GW Pharmaceuticals plc.
(UK)
Licenses for developing and marketing Sativex in US

Co-development in the field of central nervous system and oncology

Pierre Fabre Pierre Fabre (France) Business related to Busulfex in European countries
Bristol-Myers Squibb Company Bristol-Myers Squibb
Company (US)
Joint business related to SPRYCEL
(and IXEMPRA)

Ophthalmology

千寿製薬株式会社 Senju Pharmaceutical
Co., Ltd. (Japan)
Co-promotion of Mikeluna combination ophthalmic Solution, Mikelan ophthalmic solution and Mikelan LA ophthalmic solution
Co-marketing of OPEGUARD NEO KIT
富山化学 Toyama Chemical
Co., Ltd. (Japan)
License for OZEX ophthalmic solution

Diagnostics

栄研化学株式会社 Eiken Chemical
Co., Ltd. (Japan)
Co-marketing of RAPIRUN
Co-marketing of Uropaper

Co-research and co-development of diagnostics

デンカ生研株式会社 Denka Seiken
Co., Ltd. (Japan)
License for Quick Navi series

The companies are listed alphabetically within each category.